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Abstract: This study was designed to evaluate the rnorphornetric changes of parenchyrnal 
cells in the periportal (Zl) and perivenous (Z3) zones of the liver lobules that occur after 
Streptozotocin-induced diabetes in rats. Twenty male rats were allocated in two groups of 
normal and diabetic. Hyperglycemia in rats induced by 80 mg kg-1 Streptozotocin 
intraperitoneally. The blood glucose concentration was measured by using a Glucorneter in 
1st, 3rd and 5th week. After five weeks, with using anesthesia liver removed. Liver 
specimens were fixed in buffered formaldehyde and embedded in paraffin. Hematoxylin and 
eosin stained sections were used for quantitative morphometric analysis. Morphometric 
parameters in mononuclear cells were measured by Olysia software. All data are shown as 
mean with standard error of means and analyzed using the Student's t-test and p-value less 
of 0.05. Mean areas of hepatocyte, their nuclei and nucleolus were reduced by 
approximately 1.29, 7.27 and 0.76% in zone 1 in the diabetic rats in comparison with the 
control group. \Vhile mean areas ofhepatocyte, their nuclei and nucleolus were increased by 
approximately 5.26, 2.53 and 3.10%, respectively, in wne 3 in the diabetic and control rats. 
It is concluded that Streptozotocin injection leads to reduction in area ofhepatocytes and 
their nuclei and nucleolar in zone 1 and an increase in area ofhepatocytes and their nuclei and 
nucleolar in zone 3. 
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INTRODUCTION 
Diabetes is a chronic disease with a relatively high prevalence in many populations throughout 
world (Jerrold, 2000). The liver plays a central and crucial role in the regulation of carbohydrate 
metabolism. Its normal filllctioning is essential for the maintenance of blood glucose levels and of a 
continued supply to organs that require a glucose energy source. The liver uses glucose as a fuel and 
also has the ability to store it as glycogen and synthesize it from noncarbohydrate precursors 
(gluconeogenesis) (Levinthal and Tavill, 1999). 
This central role for the liver in glucose homeostasis offers a clue to the pathogenesis of glucose 
intolerance in liver diseases but little insight into the mechanisms of liver disease in diabetes mellitus 
(Levinthal and Tavill, 1999). Liver disease may cause or contribute to, be coincident with, or occur as 
a result of diabetes mellitus such as: hepatitis, autoirnrnilllebiliary disease, glycogen deposition, fibrosis 
and cirrhosis (Silverman et al., 1990; Levinthal and Tavill, 1999). Quantitative morphometric changes 
of the liver are largely unexplored in diabetes. 
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Streptozotocin (STZ), a N-nitroso-N-rnethylurea derivative of 2-deoxy-D-glucose, is 
a diabetogenic agent acting through the selective destruction of pancreatic islet P-cells 
(JlUlod et al., 1967; Stauffacher et al., 1970) and widely used for induction of diabetes in experimental 
animals (Aughsteen et al., 2006; Koyuturk et al., 2005; Bolkent et al., 2004; Stauffacher et al., 1970). 
It is known that STZ displays hepatotox:ic and nephrotox:ic activity (Bolkent et al., 2004; 
Piyachaturawat et al., 1991). 
This study was aimed at exploring the quantitative rnorphornetric changes ofparenchyrnal cells 
in the periportal (Zl) and perivenous (Z3) zones of the liver lobules that occur at early stages in 
Streptozotocin-diabetic rats using quantitative rnorphornetry under a light microscope. 
MATERIALS AND METHODS 
Animals 
Twenty male adult Wistar albino rats with 125-175 g weight were used for this study. The rats 
were housed in groups of tlrree in standard animal cages and kept llllder standard Laboratory conditions 
in Gorgan University of Medical Sciences in 2006. Animals had free access to rat pelleted chow and 
tap water. 
Experimental Design 
Twenty rats were allocated in the following groups. 
Group I Normal control rats. Saline IP for one time. 
Group II Diabetic rats. 80 mg kg-1 STZ IP one dose. 
In this group, hyperglycemia was induced with the single intraperitoneal (i.p.) injection of 
Streptozotocin, purchased from Sigma, 80 mg kg-1 body weight dissolved in distilled water just before 
use to overnight fast rats. Glucose levels from the blood of the tail vein of the rats were measured with 
a Glucometer. 
Glucose Tolerance Test 
Intraperitoneal Glucose Tolerance Test (GTT) was performed on 16 h fasted rats using 2 g 
glucose kg-1 body weight. In all groups, blood was collected from the animals by tail snipping at 0, 30, 
90 and 120 min after glucose load. Also glucose test were performed after IP injection STZ in 1, 3 
and 5 weeks. 
All the animals were deeply anesthetized with ether after 5 weeks from the begirming of the 
experiment. Then the livers were removed and fixed in natural buffered formaldehyde fixative. 
Section of hepatic tissue obtained from the left lateral and right posterior lobes and sliced at 5 nm 
thickness and embedded in paraffin wax after overnight machine processing for histological 
examination. Hematoxyline and eosin (H and E)-stained sections (Bancroft and Gamble, 1990) at 5 µm 
thickness were used for morphological and morphometric analysis. 
Morphometric Measurements 
The area measurements of hepatocytes were made using the Olympus BX-51T-32E01 
research microscope connected to DP 12 Camera with 3.34 million pixel resolution and Olysia Bio 
software (from: Olympus Optical Co. Ltd., Tokyo-Japan) in zone 1: liver cells near the portal 
area (Zl: periportal) and zone 3: hepatocytes in the centrilobular regions of the hepatic lobule 
(Z3: perivenous). 
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For each hepatocyte, total cellular area, nuclear area and nucleolar area were measured. The 
outline of each hepatocyte initially was measured followed by the outline of the nucleus using a 40X 
objective. A separate measurement for nuclei and nucleoli was performed using the same 
methodology but using a 1 OOX oil objective. At least 50 nuclei from each zone (total 100) were 
measured from each liver. 
Morphometric Variables 
The following variables were used in this study to measure the light microscopy changes 
(Zaitoun et al., 2005): 
Area The total area of the whole hepatocyte, nucleus and nucleolus in 
mononuclear cells. 
Perimeter The perimeter of whole hepatocytes. 
Diameter The diameter of nucleus. 
Long axis The long axis of the nucleus. 
Short axis The short axis of the nucleus. 
Hepatocyte area ratio The ratio ofmean area ofwhole hepatocytes to the mean area of their nuclei. 
Nuclear area ratio The ratio of the mean area of nuclei to the mean area of their nucleoli. 
Cytoplasmic area The hepatocyte area minus nuclear area 
Area difference Nuclear area minus nucleolar area. 
Statistical Analysis 
Results were expressed as mean and standard error of the means (SE). The statistical analysis was 
performed with the Student's t-test by means of the SPSS Version 11.5 software two-tailed p-values 
less than 0.05 were considered to indicate statistical significance. 
RESULTS 
Changes in the Total Area of Hepatocytes 
Quantitative parameters ofhepatocyte area, perimeter, cytoplasmic area and cell/nuclear ratio in 
hepatocytes of zone 1 and zone 3 in diabetic and normal rats are given in Table 1. 
The mean area ofhepatocyte in Zl was smaller in diabetic group in comparison with control 
group. This difference was not significant (p<0.05). Whereas in zone 3 the mean area ofhepatocytes 
in diabetic group was greater than that in control group, significantly (p<0.05). 
Changes in the Nuclei 
The changes in the nuclei in both groups of animals are shown in Table 2. Nuclear area and 
perimeter, nuclear diameter, long axis and short axis were significantly reduced in diabetic group in Zl. 
The mean area ofhepatocyte nuclear in Zl in diabetic group was smaller than that in control group. 
This difference was significant (p<0.05). The mean area ofhepatocyte nuclear in Z3 had a rare increase 
in diabetic group in comparison with control group, which was not found statistically significant. 
Changes in the Nucleolar Area 
Table 3 shows the results ofnucleolar areas. The changes in nucleolar areas in both groups were 
not significant in Zl and Z3. Furthermore there were significant changes for Zl in area difference and 
nuclear/nucleolar ratio between diabetic and control group. 
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Table 1: Quantitative parameters of hepatocyte area, perimeter, cytoplasmic area and cell/nuclear ratio in hepatocytes of zone 1 
and zone 3 in diabetic and normal rats (n =10) 
Hepatocyte area (µm)' Hepatocyte perimeter (µm) Cytoplasmic area (µm)' Cell/nuclear ratio 
Groups Zl ZJ Zl Z3 Zl ZJ Zl Z3 
Control 260.82±4.92 263.90±4.80* 67.24±0.67 68.09±0.64 212.05±4.58 216.11±4.50* 5.46±0.10* 5.66±0.11 
II STZ 257.45±4.08 277.77±3.45* 65.68±0.51 68.02±0.48 212.24±3.54 228.78±3.19* 5.85±0.09* 5.81±0.09 
Results are expressed as mean± SE of the mean. *: p<0.05 
Table 2: quantitative parameters ofhepatocyte nuclei in zone 1 and zone 3 in diabetic and normal rats (n =10) 
Nucleus area (µm)' Nucleus perimeter (µm) Diameter of nucleus 
Groups Zl Z3 Zl Z3 Zl ZJ 
Control 48.76±0.81* 47.78±0.80 29.50±0.26** 28.89±0.26 7.75±0.04** 7.56±0.06 
II STZ 45.21±0.85* 48.99±0.74 27.59±0.33** 28.24±0.26 7.45±0.06** 7.47±0.06 
Long axis (µm) Short axis (µm) 
Groups 	 Zl ZJ Zl ZJ 
Control 8.15±0.05** 7.96±0.07 7.35±0.05* 7.17±0.07 
II STZ 7.78±0.07** 7.83±0.07 7.13±0.07* 7.12±0.06 
Results are expressed as mean± SE of the mean. *: p<0.05, **: p<0.001 
Table 3: 	 Quantitative parameters of nucleolar areas, area difference (Nuclear minus nucleolar areas) and nuclear/nucleolar ratio 
from hepatocytes in zone 1 and 3 in diabetic and normal rats (n = 10) 
Nucleolus area (µm)' Area difference (µm)' Nuclear!Nucleolar ratio 
Groups 
II 
Control 
STZ 
Zl 
5.25±0.12 
5.21±0.14 
ZJ 
5.16±0.13 
5.32±0.13 
Zl 
43.51±0.77** 
39.99±0.77** 
Z3 
42.62±0.74 
43.66±0.69 
Zl 
9.85±0.22* 
9.25±0.20* 
Z3 
9.87±0.21 
9.80±0.22 
Results are expressed as mean± SE of the mean. *: p<0.05, **: p<0.001 
DISCUSSION 
In the present study, we assessed the histological changes at the light microscopy level using 
quantitative techniques and we have studied the effect of STZ on zone 1 and 3 of the liver lobules. The 
morphometric analysis determined that the area of hepatocytes decreased in zone 1 that was not 
significant whereas in zone 3, area of hepatocytes increased significantly in comparison with control 
group. 
The functions of STZ on the liver were explained by the different mechanisms. Single 
dose administration of STZ produces diabetogenic effects in rats (Koyuturk et al., 2005; 
Bolkent et al., 2004; Stauffacher et al., 1970). Also, STZ exhibits hepatotoxic activity on the liver in 
rats (Piyachaturawat et al., 1991; Watkins et al., 2000; Bolkent et al., 2004). The STZ diabetic animals 
may exhibit most of the diabetic complications through oxidative stress (Petlevski et al., 2003; 
Ozturk et al., 1996). Oxidative stress investigates by a decrease in the activity of antioxidant enzymes 
(Rajasekaran et al., 2005; Bulkentet al., 2004; Rauscher et al., 2000; GlUles et al., 1999) and an increase 
in the lipid peroxidation and free radicals. The efficiency of this defense mechanism is altered in 
diabetes and, therefore, the ineffective scavenging offree radicals may play a crucial role in determining 
tissue damage (Wohaieb and Godin, 1987). In diabetes mellitus excess glycogen accumulation by 
gluconeogenesis (Consoli et al., 1989; Ferrannini et al., 1990) leads to vacuolization in cytoplasm and 
hepatocyte nuclei (Glick et al., 1987) and may exhibit hepatomegaly and liver abnormalities 
(Chatila and West, 1996; Sanchez et al., 2000). Oxidative energy metabolism and gluconeogenesis 
protective metabolism are catalyzed mainly in the periportal zone, glucose utilization, glycogen storage 
and lipid formations are predominant in the perivenous zone (Jllllgermann and Kietzman, 1996; 
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Katz, 1992). The defense intracellular mechanisms and the activity ofnuclei and subcellular structures 
during mechanism pathways in hepatocytes may be effect on the measurement of cells and cause the 
rnorphornetric changes in the liver in diabetic rats. Increasing ofhepatocytes size is comparable with 
studies of other authors (Kurue et al., 1994, 2005; Sanchez et al., 2000). Herrman et al. (1999) 
reported diabetes rnellitus in both humans and animals leads to structural and fimctional changes 
including hepatornegaly. Also Kurne et al. (1994), observed an appearance of cytornegalic hepatocytes 
in some diabetic mice, due to an increase in number of intracytoplasrnic acidophilic granules and 
mitochondria. However some studies have shown enhance reduction ofhepatocytes volume in both 
of zonation in STZ-diabetic rats (Noorafshan et al., 2005). 
We also foillld a reduction in the hepatocyte nuclear area in zone 1 significantly and a rare increase 
of the hepatocyte nuclear area in zone 3 and a small change in area of their nucleolar that were not 
significant after STZ injection. Nuclei are responsible for production of RNA and consequent protein 
synthesis. In non-mitotic cells, nuclear volume had been shown to be closely related to DNA content 
and the level of activity (Sorensen et al., 1990; Christie and Le Page, 1961; Henrique et al., 1997). 
Even in mitotic cells such as hepatocytes of rat, changes in nuclear size without change in the 
ploidy have been related to changes in protein synthesis and nuclear activity (Kurne et al., 1994; 
Christie and Le Page, 1961). Loss of rough endoplasmic reticulum, reduced amino-acid and a decrease 
in reticulum-bolUld ribosomes were occurred in insulin-deficient animals (Thompson et al., 1981; 
Lenk et al., 1992; Kurue et al., 1994; Thakran et al., 2004). These findings suggest that patients with 
diabetes have a defect in secretory protein synthesis. Therefore, decreasing in nuclear or cell volume 
may relate a reduction of metabolic activity of liver cells and inadequate levels of insulin 
(Noorafshan et al., 2005). Although, Doi et al. (1997) had been shown the area ofhepatocyte nuclei 
in diabetic mice was about two times larger than that in control mice. Also, they reported that the 
nuclei of binuclear hepatocytes of control mice were roillld and identical in ultrastructural 
appearance. 
In this study other parameters such as cytoplasmic area, cell/nuclear ratio, diameter ofnuclei, area 
difference and nuclear/nucleolar ratio have changed. The consideration of the data established these 
changes were in agreement with the changes ofhepatocytes and their nuclei area. 
In conclusion, streptowtocin injection lead to a reduction in area ofhepatocytes and their nuclei 
in zone 1 and an increase in area ofhepatocytes and their nuclei in zone 3 of the liver lobules at early 
stages. The investigation of these changes may be useful for studies of liver pathology in patients with 
diabetes mellitus. 
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